Medication Updates
Browse by Year:
Browse by Medication:   


FDA Medication Updates
Medication news, updates and drug safety information on non-controlled substances.
DEA 2010 Pharmacist’s Manual
Guide to Federal Controlled Substances Act and its regulations as they pertain to the pharmacy profession.
NIMH Mental Health Medications Guide
Types of meds used to treat mental disorders, side effects, directions for taking, and FDA warnings.


FDA approves Tanzeum to treat type 2 diabetes
Tanzeum is a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalize blood sugar levels.
FDA approves new hand-held auto-injector to reverse opioid overdose
Evzio (naloxone hydrochloride injection) rapidly delivers a single dose of the drug naloxone via a hand-held auto-injector.
Effexor XR 150 Mg Extended-Release Capsules (Pfizer) & Venlafaxine HCl 150 Mg Extended-Release Capsules (Greenstone): Recall
This recall is due to the possible presence of Tiosyn (dofetilide) capsules.
FDA approves Farxiga to treat type 2 diabetes
The FDA has approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.


Methylphenidate ADHD Medications: Risk of Long-lasting Erections
FDA is warning that methylphenidate products may in rare instances cause prolonged and sometimes painful erections known as priapism.
Opioids Effective for Restless Legs Syndrome
A new study found that prolonged-release opioid treatment produced relief of symptoms in patients with severe restless legs syndrome. (via Medscape)
National Drug Threat Assessment
Released by the DEA, provides an up-to-date look at the many challenges local communities face related to drug abuse and drug trafficking.
First Generic Versions of Cymbalta Approved
The FDA approved the first generic versions of Cymbalta (duloxetine delayed-release capsules), used to treat depression and other conditions.
Zyprexa Relprevv (Olanzapine Pamoate)
FDA is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv.
New Federal Guidelines for Managing Occupational Exposures to HIV
The PEP regimens in the guidelines encourage consistent use of a combination of three or more drugs that are better tolerated
The FDA has approved label changes specifying new dosing recommendations for zolpidem products
SAMHSA DAWN Report: Increase in Emergency Department visits for adverse reactions involving Zolpidem
FDA approves abuse-deterrent labeling for reformulated OxyContin.
Antipsychotics in Adults
Clinician summary on antipsychotics for schizophrenia and bipolar disorder
Benztropine Mesylate Injection
Fresenius Kabi USA is voluntarily recalling four lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials
Rosiglitazone-containing diabetes medicine - 2010 FDA Restrictions Removed
Recent data does not show an increased risk of heart attack for rosiglitazone-containing drugs.

APNA is not responsible for the content of external websites.